Complications of the diabetic patient with COVID-19.

  • José Leonardo Cedeño Torres Universidad Laica Eloy Alfaro de Manabí
  • Karol Cristina Muñoz López Universidad Laica Eloy Alfaro de Manabí
  • Luis Carlos Alonzo Tumbaco Universidad Laica Eloy Alfaro de Manabí
  • Ilya Isadora Casanova Romero Universidad Laica Eloy Alfaro de Manabí
Keywords: Type 2 diabetes, COVID-19, Sars-Cov2 infection

Abstract

The complications of diabetic patients at the Manta General Hospital are analyzed in the period March 2020 - March 2021. It was a quantitative, descriptive, and retrospective study. The results indicated that 62.7% of diabetic patients treated for COVID-19 correspond to men with a dominant age range between 61-70 years with 33.5%; 52.2% of diabetics had moderate lung involvement and 33.4% severe; Acute Respiratory Insufficiency Syndrome was present in 58.2% and 66.1% had severe hypoxemia as a complication; 32.3% of diabetics were admitted to the Intensive Care Unit (ICU), and of the total admitted, 86.5% died. It is concluded that most of the patients presented moderate to severe complications during the Sars-CoV2 infection with a high mortality in the ICU.

References

Abu-Farha, M., Al-Mulla, F., Thanaraj, T. A., Kavalakatt, S., Ali, H., Abdul Ghani, M., & Abubaker, J. (2020). Impact of diabetes in patients diagnosed with COVID-19. Frontiers in immunology, 11, 576818.

Alejandro, E. U., Mamerto, T. P., Chung, G., Villavieja, A., Gaus, N. L., Morgan, E., & Pineda-Cortel, M. R. B. (2020). Gestational diabetes mellitus: a harbinger of the vicious cycle of diabetes. International journal of molecular sciences, 21(14), 5003.

Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., ... & Rodriguez-Morales, A. J. (2020). Coronavirus disease 2019–COVID-19. Clinical microbiology reviews, 33(4), e00028-20.

Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., De Boer, I. H., ... & Vafiadis, D. K. (2015). Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation, 132(8), 691-718.

Halvatsiotis, P., Kotanidou, A., Tzannis, K., Jahaj, E., Magira, E., Theodorakopoulou, M., ... & Dimopoulos, G. (2020). Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity. Diabetes research and clinical practice, 166, 108331.

Kazi, A. A., & Blonde, L. (2001). Classification of diabetes mellitus. Clinics in laboratory medicine, 21(1), 1-13.

Kerbl, R., & Zepp, F. (2021). Coronavirus disease 2019. Monatsschrift Kinderheilkunde, 169(4), 308-311.

Khan, R. M. M., Chua, Z. J. Y., Tan, J. C., Yang, Y., Liao, Z., & Zhao, Y. (2019). From pre-diabetes to diabetes: diagnosis, treatments and translational research. Medicina, 55(9), 546.

Moderbacher, C. R., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., ... & Crotty, S. (2020). Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell, 183(4), 996-1012.

Pasquel, F. J., & Umpierrez, G. E. (2014). Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes care, 37(11), 3124-3131.

Varghese, P. M., Tsolaki, A. G., Yasmin, H., Shastri, A., Ferluga, J., Vatish, M., ... & Kishore, U. (2020). Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology, 225(6), 152008.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., ... & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061-1069.

World Health Organization. (2022). COVID-19 weekly epidemiological update, edition 97, 22 June 2022. https://apps.who.int/iris/handle/10665/357163

Wu, C., Chen, X., Cai, Y., Zhou, X., Xu, S., Huang, H., ... & Song, Y. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine, 180(7), 934-943.

Yan, Y., Yang, Y., Wang, F., Ren, H., Zhang, S., Shi, X., ... & Dong, K. (2020a). Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ open diabetes research and care, 8(1), e001343.

Yang, H., Sloan, G., Ye, Y., Wang, S., Duan, B., Tesfaye, S., & Gao, L. (2020). New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine. Frontiers in endocrinology, 10, 929.

Zhang, J. Y., Shang, T., Ahn, D., Chen, K., Coté, G., Espinoza, J., Mendez, C. E., Spanakis, E. K., Thompson, B., Wallia, A., Wisk, L. E., Kerr, D., & Klonoff, D. C. (2021). How to Best Protect People with Diabetes from the Impact of SARSCoV-2: Report of the International COVID-19 and Diabetes Summit. Journal of Diabetes Science and Technology, 15(2), 478–514.

Zhang, Y., Cui, Y., Shen, M., Zhang, J., Liu, B., Dai, M., ... & Pan, P. (2020). Association of diabetes mellitus with disease severity and prognosis in COVID-19: a retrospective cohort study. Diabetes research and clinical practice, 165, 108227.

Zimmet, P. Z. (2017). Diabetes and its drivers: the largest epidemic in human history? Clinical diabetes and endocrinology, 3(1), 1-8.

Published
2022-12-01